TABLE III -.
Binary outcomes: variable importance ranking for myogenic genes
| Gene name | Standard abbreviation | Ranking |
|---|---|---|
| IMATd = below or above 15% intramuscular adipose tissue; RPrI = recurrent pressure injury. | ||
| (a) RPrI as outcome | ||
| IMAT% | 6.01 | |
| Dysferlin 2B | DYSF2B | 2.76 |
| Mitogen-activated protein kinase 1 | MAPK1 | 2.76 |
| Lamin A/C | LMNA | 2.25 |
| Calpain 3 | CAPN3 | 1.88 |
| AKT serine/threonine kinase 1 | AKT1 | 1.50 |
| Mitogen-activated protein kinase 14 | MAPK 14 | 1.50 |
| Caspase 3, apoptosis related | CASP3AR | 1.26 |
| Adrenoceptor beta 2 | ADRB2 | 1.26 |
| Myocyte enhancer factor 2C | MEF2C | 1.26 |
| (b) IMATd as outcome | ||
| Pyruvate dehydrogenase kinase 4 | PDK4 | 5.09 |
| Lamin A/C | LMNA | 2.78 |
| Matrix metallopeptidase 9 | MMP9 | 2.78 |
| Transforming growth factor beta 1 | TGFB1 | 2.78 |
| Ribosomal protein S6 kinase, polypeptide 1 | RPS6KA1 | 2.31 |
| Utrophin | UTRN | 2.31 |